TMEM240 and metastatic neoplasm: The TMEM240 protein level decreased in 91.7% (100/109) of tumors from CRC patients and in 75.0% (24/32) of the metastatic tumors from CRC patients but exhibited higher expression in 75.0% (6/8) of the normal colon tissues (Fig. 5, Table 1).